Introduction
Colorectal cancer (CRC) is the third most common malignancy, with a major cause of mortality by metastasis [1] [2] . Besides the hematogenous and lymphatic routes, CRC usually gives rise to transcoelomic spread and ultimately causes peritoneal carcinomatosis (PC) [3] [4] [5] . PC is encountered in around 7% of patients at primary surgery, in 4% to 19% of patients during follow-up after curative surgery, in up to 40% to 80% of patients who succumb to CRC 4 .
In the past, the CRC patients with PC are considered as being in the terminal phase of their disease, and receive only supportive treatments, including the palliative surgery and systemic chemotherapy, achieving a survival rate not exceeding 7 months with 5-FU and Leucovorin 6 , reaching up to 23.4 month survival with Oxaliplatine and Irinotecan 7 . In the last decade, PC is considered as an initial loco-regional disease and renewed approaches for this disease are contributed by many research groups. The complete cytoreduction of macroscopic disease combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has shown curative benefits on colorectal PC [8] [9] , achieving overall survival rates up to 46 months and five-year survival rates up to 51% 7 .
The occurrence of colorectal PC relies on two important steps 10 . Firstly, the primary CRC cells need spread into peritoneal cavity. The primary invasive CRC could break through the bowel all and the cancer cells might fell off 11 . This case is encountered at primary surgery, with an incident rated around 7% 12 . The most frequent route for peritoneal dissemination comes from surgery-resulted rupture of bowel and vascular system 4 . The invading cancer cells in the lymphatic and blood vessels disseminate into the Ivyspring International Publisher peritoneal cavity and targets a more adaptable microenvironment for malignant development. It's reported that this kind of PC cases account for up to 19% of postoperative patients 4 . Secondly, the disseminated cancer cells need target and colonize in a peritoneal tissue or organ, which could provide a pro-tumor microenvironment.
It's reported that the PC of gastrointestinal cancers and ovarian cancers prefers to grow in omentum majus. Some groups demonstrate, in a ovarian PC model, that fat tissues support tumor growth by providing the cancer cells with fatty acids [13] [14] . However, few studies mentioned the immune status in PC progression, perhaps due to the lack of in vivo PC model with competent immunity. Subsequently, the exploration of immunotherapy for PC was restrained, although the T cell-based immunotherapy had obtained a great achievement in many terminal cancers 15 . In the present study, we set up a colorectal PC model in immune-competent mice and revealed the alteration of adaptive immunity in PC development. Our study might potentiate the research and therapy strategies of colorectal PC.
Materials and Methods

Cell lines
Mouse colorectal cancer cell lines MC-38 cells were provided by JENNIO Biological Technology (Guangzhou, China) and MC-38G (GFP-tagged MC-38 cells) were maintained in our research group. Those cells were maintained in Dulbecco's modified Eagle's medium (DMEM) high glucose, supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/ml) and streptomycin (100 ug/ml), in a 5% CO2 atmosphere at 37 °C.
Animal model
All the animal experiments were approved by the Institutional Animal Care and Use Committee at Third Military Medical University (TMMU), and all the experiments were performed in accordance with the "Guide for the care and use of laboratory animals" published by the US NationalInstitutes of Health (publication no. 85-23, revised 1996). All the mice were housed in a pathogen-free facility with a 12-h light, 12-h dark cycle in TMMU. All the mice were provided with food and purified water ad libitum. Each cage contained no more than 5 mice. MC-38 cells and MC-38G cells (1 × 10 6 cells in 0.1 ml PBS) were intraperitoneally injected into abdominal cavity of 6 week-old male C57BL/6 mice. Then the tumorinoculated mice were observed dynamically. The pathological observation of PC development including tumor infiltration and systemic parameters were performed on day 0, 5, 10, 15 and 20. The alteration of T cells and B cells was evaluated on day 0, 3, 5, 7 and 9. The production of IFN-γ in T cells was measured on day 0, 5, 10 and 15.
HE staining
Organs and tissue were harvested, formalinfixed, and processed into paraffin blocks, and then sections were cut and stained with hematoxylin and eosin (C0105, Beyotime, China).
Immunofluorescence staining
All tissue samples were fixed and processed into paraffin blocks. After dewaxing, antigen repair (10 mmol/L sodium citrate for 5 min in a pressure cooker) and removing endogenous enzymes in Hydrogen Peroxide Block, the sections were incubated with the primary antibodies anti-GFP (ab13970, Abcam, UK, the dilution ratio was 1:500) and anti-Perilipin (ab3526, Abcam, UK, the dilution ratio was 1:200) at 4ºC overnight. Then the samples were incubated in secondary antibody (703-545-155, Jackson ImmunoResearch, USA; ab150074, Abcam, UK, the dilution ratio was 1:500) for 1-2 h at room temperature in the dark. After rinsing three times in 1X PBS for 5 min each, the slides were counterstained with Hoechst (C1026, Beyotime, China, the dilution ratio was 1:500) to reveal cell nuclei. Finally, fluorescence microscopy was used to evaluate specimen.
Immunostaining and fluorescence-activated cell sorting (FACS)
Mice were sacrificed by CO 2 . The spleen was dissected and gently rubbed between the two rough sides of frosted slides (#FSL006, Beyotime, Shanghai, China). Splenic samples were isolated by gently lapping spleens over a 75-μm filter (F513442, Sangon Biotech, China), and then washing in FACS buffer (PBS with 0.5% endotoxin-free FBS, 2 mM EDTA, and 25 mM HEPES). After spinning down for 5 min at 500g, erythrocytes were removed by ACK lysis buffer (R1010, Solarbio, China) for 5 minutes. Then the reaction was stopped by adding equivoluminal PBS buffer and splenocytes were collected by centrifugation. Finally, cell pellet were resuspended with FACS buffer.
Circulating blood samples were collected using blood collection tubes (171001, KANG JIAN, China) to prevent clotting. After using mouse peripheral blood lymphatic separation kit (#P8620, Solarbio, China), cells were collected and lysed in ACK lysis buffer as described above. In the same way, blood samples were resuspended in FACS buffer.
Adipose tissue were resected from mice and mechanically dissociated with ophthalmic forceps into about one cubic millimeter and then digested with 25 ml Roswell Park Memorial Institute (RPMI) 1640 medium, supplemented with 3% FBS and 1mg/ml collagenase IV ( A004186, Sangon Biotech, China) for 45 min at 37 °C. Meanwhile the solution was vibrated by magnetic stirrer. After dissociation, adipose tissue suspensions were filtered through a 75-μm filter, and were spun down for 10 min at 500g. Then adipose tissue samples were lysed with ACK buffer as above, and then resuspended in FACS buffer.
At last, after staining with antibodies at 4 °C for 45 min followed by 2 washes in FACS buffer, the cells were resuspended in FACS buffer for FACS analysis (FACSVerse C6, BD Biosciences). The antibodies included APC anti-mouse CD45 antibody (#103112, Biolegend), PE anti-mouse CD90.2 antibody (#105308, Biolegend), PerCP/Cy5.5 anti-mouse CD8a antibody (#100734, Biolegend), and APC/Cy7 anti-mouse CD4 (#105308, Biolegend).
Treatment of antibodies in vivo
The antibody treatment was performed as described previously 16 . Briefly, MC-38 cells (1 × 10 6 cells in 0.1 ml PBS) were intraperitoneally injected into abdominal cavity of 6 week-old male C57BL/6 mice. Then, the MC-38 tumor-bearing mice were treated with monoclonal antibodies anti-CD8 (MAB116, Novus Biologicals) or IgG (MAB002, Novus Biologicals) as control. Tumor cells were inoculated on day 1. Each mouse was treated 3 times (days 4, 7 and 10) via the tail vein at a dose of 100 ug/day. The tumor nodes in visceral fats were checked on day 15.
Statistical analysis
All analyses were performed using GraphPad Prism 5. All data were expressed as the mean± s.e.m., and were analyzed using two-tailed unpaired T-test. For all statistical analyses, * indicates P< 0.05, ** indicates P<0.01, and *** indicates P<0.005.
Results
CRC cells mainly target the visceral fat tissues
To mimic the disseminated CRC cells in peritoneal cavity, a mouse colorectal cancer cell line MC-38 was employed for intraperitoneal inoculation in C57BL/6 mice. The PC progression was observed dynamically. We demonstrated that the PC nodes were visible 15 days post inoculation in our experimental system ( Figure 1A-E) . Interestingly, the PC nodes mainly located in visceral fats, such as omentum majus ( Figure 1B) , mesenterium ( Figure 1C ) and epididymal fats ( Figure 1E ). After 20 days of inoculation, the PC nodes could be observed in almost all the visceral fat tissues, even in perirenal fats ( Figure 1D) . Meanwhile, the body weight of tumor bearing mice was significantly lost in comparison with the tumor-free mice (Table 1) . However, the weight of organs like spleen, kidney, lung and liver didn't differ notably between the PC and control group (Table 1) . It should be pointed out that the tumor-bearing mice usually died around 25 days post tumor injection (data not shown). To further confirm the target of CRC cells in PC development, we dissected the visceral organs, such as guts, livers, lungs, kidneys and spleens. No tumor nodes were observed in gross anatomy of those organs 20 days post of tumor inoculation, except the mesenterium attached to guts (Figure 2A) . We also didn't find any tumor lesions in spleens, kidneys, lungs or livers from tumor bearing mice with pathological observation ( Figure 2B ).
CRC cells quickly invaded into the visceral fats
In the present PC model, CRC cells mainly migrated to the visceral fat tissues. As shown in Figure 3A , the epididymal fats were isolated and easy to investigate. Thus we choose this fat tissue to dynamically assess the progression of colorectal PC. In consistence, the PC nodes in epididymal fats were visible 15 days post tumor injection ( Figure 3A) . With HE staining, we could find CRC cell infiltration on day 10 after setup of the present PC model ( Figure  3B ). To further characterize the detailed metastasis in epididymal fat, the GFP-tagged MC-38 cells were used to set up the PC model. We demonstrated, on day 5 post PC model setup, that the MC-38 tumor cells were infiltrated in the epididymal fat ( Figure 3C ). This result indicated that the inoculated CRC cells could rapidly migrate into the visceral fat tissues.
The status of systemic adaptive immunity in the colorectal PC model
Adaptive immunity plays a crucial role in the development of tumors, and T cell-based immunotherapy is increasingly being approved for clinical use 15, 17 . The CD8 + T cells, also known as cytotoxic T lymphocyte, can directly attack foreigners such as bacteria, viruses, and cancer cells once they become activated 18 . By contrast, CD4 + T cells (mature T-helper cells) mainly organize an immune response through indirectly recruiting other immune cells 19 . Therefore, we further measured the adaptive immune alteration in spleen and blood with immunostaining and FACS. We found the ratios of T cells and B cells in spleens were not altered significantly in response to tumor injection ( Figure 4A-B) . Further, the spleen CD4 and CD8 subsets of T cells were also assed and no obvious differences were observed after PC setup ( Figure 4C) .
Noteworthily, numbers of blood T cells underwent a quick decrease with PC development, while blood B cells didn't alter notably ( Figure 5A-B) . In details, the ratios of blood CD4+ T cells decreased slightly over time after tumor inoculation, whereas the ratios of CD8+ T cells increased significantly ( Figure 5C ). In comparison with CD8, the amount of blood CD4+ T cells continuously decreased with PC progression (Figure 5B-C) . 
The status of local adaptive immunity in the colorectal PC model
Comparing with the systemic immunity, the local immunity in tumor microenvironment appears more effective. Therefore, we further investigated the adaptive immunity alteration in visceral fats and the epididymal fat was selected as a representative. With FACS analysis, we demonstrated that the amount of T cells was continuously increased over time after tumor inoculation, while the B cells altered modestly ( Figure 6A-B) . Further, we found the ratio of CD4+ T cells increased on day 5 after tumor injection, while declined to basal levels quickly ( Figure 6C ). More interestingly, the ratio of fat CD8+ T cells was decreased on day 5 after tumor inoculation and quickly restored and increased over time ( Figure 6C) . Combining with the alteration of total T cells in fats, we concluded that the amount of fat CD8+ T cells was continuously increased in the process of PC development.
It's reported that the tumoricidal T cells would be exhausted with cancer progression. The exhausted T cells expressed less IFN-γ than the functional T cells 20 . Thus we further detected the IFN-γ levels in fat T cells dynamically in the PC model. We found that the levels of IFN-γ in CD4+ T cells increased by around 2 fold on day 10 after tumor injection and then began to drop, as compared to tumor-free mice ( Figure 7A-B) . However, the IFN-γ levels in fat CD8+ T cells fluctuated modestly over time ( Figure 7C ). It's interesting that the levels of IFN-γ in CD8+ T cells were much higher than that in CD4+ T cells ( Figure  7B-C) .
According to the alteration of T cell quantity and quality in the fat tissues, we presumed that the T cells were not exhausted at least before day 10 and that CD8+ T cell might be a major regulator of tumor immunity in our colorectal PC model. Next, we used CD8 antibodies to eliminate CD8+ T cells to investigate the role of CD8+ T cells in colorectal PC progression. We demonstrated that treatment of CD8 antibodies largely potentiated the development of MC-38 cell-based PC (Figure 8A-B) . Those results indicated that PC development could be modulated by immunotherapy. The present PC model can mimic the characteristics of colorectal PC in clinics. Besides, gastrointestinal and ovarian cancer PC could also be mimicked by intraperitoneal inoculation of corresponding cancer cells. It's reported that ovarian cancer cells were also predominantly colonized in visceral fats such as omentum majus, in mouse PC models 13 . It's really interesting that visceral fats are the major targets of PC in different types of cancers. The mechanisms for the attractive and supportive effects of fat tissues on peritoneal cancer cells need further to be explored. After that, potential targets for preventing colorectal PC might be revealed.
It should be pointed out that a number of PC models have been established by a number of previous and recent studies with different purposes. For general research on cancer cell biology, the PC models are mainly constructed in the nude mice by intraperitoneal inoculation of any types of cancer cells regardless of species [21] [22] . Especially, some human colorectal cancer cell lines could be implanted in nude mice to test drug effects [21] [22] . Besides, the murine MC-38 or CT-26 cell-based colorectal PC models were also established in the immune competent mice in the present or other studies [23] [24] [25] . More interestingly, the cancer PC models were also reported in rats 26 and rabbits 27 . However, few studies investigated the basic immunological changes with the PC development. The previous studies suggested that adipocytes derived fatty acids might be the major resources of substances and energy for the development of cancer cells 13, [28] [29] . However, those studies were mainly performed in PC models of immune-deficient mice. Actually, cancer progression is accompanied by immune alteration. Immunotherapy (such as PD1 and PDL-1 blockage [30] [31] ) has shown a great potential in cancer treatment. Our colorectal PC model was constructed in the immune complement mice, providing an ideal chance for immune studies. In the present study, we demonstrated that the quantity and quality of T cells in fat tissues altered dynamically with colorectal PC development. We speculated that modulation of T cell activity might be a good way to treat colorectal PC. The present model could be used for functional screening of immunotherapy-related drugs. The colorectal PC progressed quickly in our experimental model, making related studies rather convenient and reproducible. In all, here we provided a convenient and reliable colorectal PC model in mice. In this model, we demonstrated that colorectal PC preferred to colonize in visceral fats and T cells were altered dynamically with the development of colorectal PC. 
